Recurrence of left ventricular dysfunction in patients with restored idiopathic dilated cardiomyopathy

Jin-Sun Park1, Jin-Woo Kim, Kyoung-Woo Seo

  • 1Department of Cardiology, Ajou University School of Medicine, Suwon, Korea.

Clinical Cardiology
|January 24, 2014
PubMed

Insights

Recurrence of left ventricular (LV) dysfunction in recovered idiopathic dilated cardiomyopathy (DCM) is linked to older age, diabetes, and larger LV end-diastolic dimension (LVEDD). These factors predict potential LV dysfunction relapse in DCM patients. Keywords: dilated cardiomyopathy, left ventricular dysfunction, diabetes, LVEDD.

Area of Science:

  • Cardiology
  • Heart Failure Research

Background:

  • Nonischemic idiopathic dilated cardiomyopathy (DCM) can involve spontaneous left ventricular (LV) dysfunction recovery, yet recurrence is possible.
  • Predictors for LV dysfunction recurrence in recovered idiopathic DCM remain poorly understood.
  • This study examined clinical, echocardiographic, and laboratory factors influencing LV dysfunction recurrence in recovered DCM patients.

Purpose of the Study:

  • To identify clinical, echocardiographic, and laboratory variables associated with the recurrence of left ventricular (LV) dysfunction in patients who recovered from idiopathic dilated cardiomyopathy (DCM).

Main Methods:

  • Eighty-five patients with DCM who achieved LV systolic function recovery were followed for a median of 50 months.
  • Standard heart failure medications were continued throughout follow-up.
  • Clinical, echocardiographic, and laboratory data were analyzed to determine independent predictors of LV dysfunction recurrence.

Main Results:

  • Left ventricular (LV) dysfunction recurred in 33 patients.
  • Univariate analysis identified age, time to recovery, diabetes, and LV end-diastolic dimension (LVEDD) at initial presentation as associated with recurrence.
  • Multivariate analysis confirmed age, diabetes, and LVEDD at initial presentation as independent predictors of recurrence.

Conclusions:

  • Recurrence of LV dysfunction in recovered idiopathic DCM is significantly associated with older age, presence of diabetes, and LV end-diastolic dimension (LVEDD) at initial presentation.
  • These findings suggest that patients with these risk factors may require continued intensive management to prevent LV dysfunction relapse.
Abstract

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
790
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
753
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
952
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.9K
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
1.3K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
805